Most people with multiple sclerosis (MS) live for many decades after diagnosis. MS is rarely the direct cause of death, and on average it shortens life by a few years rather than dramatically. Studies in recent decades suggest the gap between people with MS and the general population has been narrowing, largely because diagnosis is earlier and treatment is better. Your own outlook depends on factors such as the type of MS you have, how early you start treatment, and your overall health.
This guide explains what the research says, what affects outlook, and what you can do to improve it.
How long do people with MS live?
Older studies estimated that MS reduced life expectancy by roughly 7 to 10 years compared with people without MS. More recent research generally finds a smaller reduction, and the figure varies depending on the country, the time period studied and the type of MS.
Three points are worth keeping in mind:
- These are averages, not predictions. Many people with MS live as long as the general population, and an average cannot tell you what will happen to one person.
- MS itself is rarely fatal. When life is shortened, it is more often through complications of advanced disability, such as infections, or through other conditions such as heart disease.
- Treatment has changed the picture. Most statistics come from people diagnosed before today’s disease-modifying therapies were available, so they may understate the outlook for someone diagnosed now.
What affects life expectancy in MS?
Type of MS
The course of the disease is one of the strongest influences on long-term outlook. We cover each type below.
Age at diagnosis
MS is most often diagnosed between the ages of 20 and 50. People diagnosed later in life, especially after 50, are more likely to have a progressive course and may accumulate disability faster.
How early treatment starts
Disease-modifying therapies (DMTs) reduce relapses and slow the build-up of new lesions. Starting early, before significant damage has accumulated, is associated with better long-term outcomes.
Level of disability
Higher levels of disability, particularly difficulty walking, swallowing or breathing, raise the risk of complications. Rehabilitation and good supportive care lower that risk.
Other health conditions and lifestyle
Heart disease, diabetes, smoking and depression can all affect survival in people with MS. Smoking in particular is linked to faster progression, and stopping smoking is one of the most useful changes a person can make.
Life expectancy by type of MS
Relapsing-remitting MS (RRMS)
RRMS is the most common form. People have clear relapses followed by periods of recovery. With modern treatment, many people with RRMS have a normal or near-normal lifespan. Relapsing MS is also the form in which life expectancy has improved the most.
Secondary progressive MS (SPMS)
Many people with RRMS eventually move to SPMS, where disability gradually worsens between or in the absence of relapses. The transition often occurs 10 to 20 years after diagnosis, though modern treatment may delay it. Outlook is generally less favourable than for RRMS because disability tends to build over time.
Primary progressive MS (PPMS)
PPMS involves steadily worsening symptoms from the start, usually without distinct relapses. It is associated with faster accumulation of disability, so the effect on life expectancy tends to be larger than for relapsing forms. Treatment options have been more limited, although this is an active area of research.
Long-term prognosis: what to expect over the years
MS affects people very differently. Some experience few symptoms for decades, while others develop significant disability sooner. Features that generally point to a milder course include:
- Onset at a younger age
- Initial symptoms involving vision or sensation rather than movement
- Complete recovery between early relapses
- Few lesions on early MRI scans
- A long gap between the first and second relapse
Features that point to a more active or progressive course include onset after 40, early motor or coordination problems, a high number of lesions, frequent early relapses and a progressive course from the start. Your neurologist can combine these signs with your scans to give you a more personal picture. For more on this topic, see our guide to the early prognosis of multiple sclerosis.
How to improve your long-term outlook
There is no single step that guarantees a better outcome, but several things consistently help:
- Get an early, accurate diagnosis. Treatment works best before extensive damage has occurred.
- Start and stay on appropriate disease-modifying therapy. Review it regularly with your neurologist.
- Do not smoke. Smoking is one of the clearest modifiable risk factors for faster progression.
- Stay physically active. Exercise and physiotherapy help with strength, balance and fatigue.
- Manage other health conditions. Control blood pressure, diabetes and cholesterol.
- Look after your mental health. Depression and anxiety are common in MS and respond to treatment.
- Get vaccinated and treat infections promptly. Infections can trigger relapses and are a leading cause of complications.
Where do stem cell approaches fit?
It is important to be clear about what the evidence shows. Autologous haematopoietic stem cell transplantation (AHSCT) has been studied in clinical trials for people with highly active relapsing MS, and some have shown reduced relapses and new lesions in carefully selected patients. It is a serious procedure with real risks, and it is not suitable for everyone. Other cell-based and exosome approaches are still being researched, and results so far are preliminary.
No stem cell treatment has been proven to extend life expectancy in MS. Anyone considering one should talk to a neurologist first, ask about the quality of the evidence, and understand the risks. You can read more about the options we assess in our guide to stem cell treatment for multiple sclerosis in India.
Frequently asked questions
Does MS shorten life expectancy?
On average, MS reduces life expectancy by a few years, though many people live as long as those without MS. The gap appears to be narrowing as treatment improves.
Can you live a normal life with MS?
Many people do. With early treatment, regular follow-up and healthy habits, a large number of people with relapsing MS work, raise families and stay active for decades.
Is life expectancy different for primary progressive MS?
PPMS tends to cause disability to build faster than relapsing forms, so the effect on lifespan can be greater. Individual outcomes still vary widely.
What is the most common cause of death in people with MS?
People with MS die most often from the same causes as the general population, such as cardiovascular disease and cancer. In people with advanced disability, complications such as infections and breathing problems are more common.
Does early treatment improve life expectancy?
Early treatment reduces relapses and slows the build-up of damage. Long-term data on survival are still developing, but starting treatment early is associated with better outcomes overall.
Talk to our team
If you or someone close to you has been diagnosed with MS and you want to understand the options, including the realistic benefits and risks of regenerative approaches, our medical team can review your reports and give you a clear, honest assessment.
